{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T02:57:58Z","timestamp":1790909878395,"version":"4.1.0"},"reference-count":75,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1097\/mot.0b013e32834cdaf2","type":"journal-article","created":{"date-parts":[[2011,10,15]],"date-time":"2011-10-15T09:25:27Z","timestamp":1318670727000},"page":"580-587","source":"Crossref","is-referenced-by-count":16,"title":["Rare, unusual, and less common virus infections after organ transplantation"],"prefix":"10.1097","volume":"16","author":[{"given":"Raymund R.","family":"Razonable","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-4-20210218","first-page":"479","article-title":"Viral infections in transplant recipients.","volume":"100","author":"Razonable","year":"2009","journal-title":"Minerva Med"},{"key":"R2-4-20210218","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1586\/eri.11.43","article-title":"Management of viral infections in solid organ transplant recipients.","volume":"9","author":"Razonable","year":"2011","journal-title":"Expert Rev Anti Infect Ther"},{"issue":"Suppl 4","key":"R3-4-20210218","doi-asserted-by":"crossref","first-page":"S161","DOI":"10.1111\/j.1600-6143.2009.02907.x","article-title":"Adenovirus in solid organ transplant recipients.","volume":"9","author":"Ison","year":"2009","journal-title":"Am J Transplant"},{"key":"R4-4-20210218","doi-asserted-by":"crossref","first-page":"2555","DOI":"10.1111\/j.1600-6143.2005.01033.x","article-title":"A surveillance study of adenovirus infection in adult solid organ transplant recipients.","volume":"5","author":"Humar","year":"2005","journal-title":"Am J Transplant"},{"key":"R5-4-20210218","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1111\/j.1600-6143.2011.03479.x","article-title":"Adenovirus disease after kidney transplantation: course of infection and outcome in relation to blood viral load and immune recovery.","volume":"11","author":"Watcharananan","year":"2011","journal-title":"Am J Transplant"},{"key":"R6-4-20210218","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1097\/01.TP.0000072808.93060.0F","article-title":"Adenovirus infection in pediatric small bowel transplantation recipients.","volume":"76","author":"Pinchoff","year":"2003","journal-title":"Transplantation"},{"key":"R7-4-20210218","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1182\/blood-2002-02-0377","article-title":"Adenovirus infections following allogeneic stem cell transplantation: incidence and outcome in relation to graft manipulation, immunosuppression, and immune recovery.","volume":"100","author":"Chakrabarti","year":"2002","journal-title":"Blood"},{"key":"R8-4-20210218","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1086\/517375","article-title":"Adenovirus infection in adult orthotopic liver transplant recipients: incidence and clinical significance.","volume":"177","author":"McGrath","year":"1998","journal-title":"J Infect Dis"},{"key":"R9-4-20210218","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1056\/NEJM200105173442002","article-title":"Association of viral genome with graft loss in children after cardiac transplantation.","volume":"344","author":"Shirali","year":"2001","journal-title":"N Engl J Med"},{"key":"R10-4-20210218","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/S0140-6736(01)05580-5","article-title":"Prediction of severe disseminated adenovirus infection by serum PCR.","volume":"358","author":"Echavarria","year":"2001","journal-title":"Lancet"},{"key":"R11-4-20210218","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1086\/505498","article-title":"Adenovirus infections in transplant recipients.","volume":"43","author":"Ison","year":"2006","journal-title":"Clin Infect Dis"},{"key":"R12-4-20210218","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.vetmic.2009.08.027","article-title":"Zoonotic aspects of arenavirus infections.","volume":"140","author":"Charrel","year":"2010","journal-title":"Vet Microbiol"},{"key":"R13-4-20210218","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1056\/NEJMoa053240","article-title":"Transmission of lymphocytic choriomeningitis virus by organ transplantation.","volume":"354","author":"Fischer","year":"2006","journal-title":"N Engl J Med"},{"key":"R14-4-20210218","first-page":"799","article-title":"Brief report: lymphocytic choriomeningitis virus transmitted through solid organ transplantation - Massachusetts, 2008.","volume":"57","year":"2008","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"R15-4-20210218","doi-asserted-by":"crossref","first-page":"2638","DOI":"10.1056\/NEJMc080743","article-title":"A new arenavirus in transplantation.","volume":"358","author":"Allander","year":"2008","journal-title":"N Engl J Med"},{"key":"R16-4-20210218","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1097\/QCO.0b013e32830ee08a","article-title":"Hepatitis E virus.","volume":"21","author":"Khuroo","year":"2008","journal-title":"Curr Opin Infect Dis"},{"key":"R17-4-20210218","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1111\/j.1600-6143.2008.02286.x","article-title":"Hepatitis E virus-related cirrhosis in kidney- and kidney-pancreas-transplant recipients.","volume":"8","author":"Kamar","year":"2008","journal-title":"Am J Transplant"},{"key":"R18-4-20210218","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1056\/NEJMoa0706992","article-title":"Hepatitis E virus and chronic hepatitis in organ-transplant recipients.","volume":"358","author":"Kamar","year":"2008","journal-title":"N Engl J Med"},{"key":"R19-4-20210218","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1002\/lt.21819","article-title":"Prevalence of hepatitis E virus infection in liver transplant recipients.","volume":"15","author":"Haagsma","year":"2009","journal-title":"Liver Transpl"},{"key":"R20-4-20210218","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1002\/lt.21480","article-title":"Chronic hepatitis E virus infection in liver transplant recipients.","volume":"14","author":"Haagsma","year":"2008","journal-title":"Liver Transpl"},{"key":"R21-4-20210218","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1136\/gut.2008.165571","article-title":"Reactivation of hepatitis E infection in a patient with acute lymphoblastic leukaemia after allogeneic stem cell transplantation.","volume":"58","author":"le Coutre","year":"2009","journal-title":"Gut"},{"key":"R22-4-20210218","doi-asserted-by":"crossref","first-page":"30","DOI":"10.3201\/eid1701.100527","article-title":"Hepatitis E virus infection without reactivation in solid-organ transplant recipients, France.","volume":"17","author":"Legrand-Abravanel","year":"2011","journal-title":"Emerg Infect Dis"},{"key":"R23-4-20210218","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1053\/j.gastro.2011.02.050","article-title":"Factors associated with chronic hepatitis in patients with hepatitis E virus infection who have received solid organ transplants.","volume":"140","author":"Kamar","year":"2011","journal-title":"Gastroenterology"},{"key":"R24-4-20210218","first-page":"121","article-title":"Chronic hepatitis E in liver transplant recipients: a significant clinical problem Minerva Gastroenterol D","volume":"56","author":"Pischke","year":"2010","journal-title":"ietol"},{"key":"R25-4-20210218","doi-asserted-by":"crossref","first-page":"173","DOI":"10.3201\/eid1702.100856","article-title":"Hepatitis E virus and neurologic disorders.","volume":"17","author":"Kamar","year":"2011","journal-title":"Emerg Infect Dis"},{"key":"R26-4-20210218","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1128\/JCM.02578-10","article-title":"Standardization of hepatitis E virus (HEV) nucleic acid amplification technique-based assays: an initial study to evaluate a panel of HEV strains and investigate laboratory performance.","volume":"49","author":"Baylis","year":"2011","journal-title":"J Clin Microbiol"},{"key":"R27-4-20210218","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.virusres.2011.06.006","article-title":"Serological diagnostics of hepatitis E virus infection.","volume":"161","author":"Khudyakov","year":"2011","journal-title":"Virus Res"},{"key":"R28-4-20210218","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.virusres.2011.05.008","article-title":"Toward the development of a hepatitis E vaccine.","volume":"161","author":"Kamili","year":"2011","journal-title":"Virus Res"},{"key":"R29-4-20210218","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1056\/NEJMoa061847","article-title":"Safety and efficacy of a recombinant hepatitis E vaccine.","volume":"356","author":"Shrestha","year":"2007","journal-title":"N Engl J Med"},{"key":"R30-4-20210218","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/S0140-6736(10)61030-6","article-title":"Efficacy and safety of a recombinant hepatitis E vaccine in healthy adults: a large-scale, randomised, double-blind placebo-controlled, phase 3 trial.","volume":"376","author":"Zhu","year":"2010","journal-title":"Lancet"},{"key":"R31-4-20210218","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1038\/ajg.2011.158","article-title":"Definitive clearance of a chronic hepatitis E virus infection with ribavirin treatment.","volume":"106","author":"Alric","year":"2011","journal-title":"Am J Gastroenterol"},{"key":"R32-4-20210218","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/j.healun.2011.03.013","article-title":"Sustained virologic response with ribavirin in chronic hepatitis E virus infection in heart transplantation.","volume":"30","author":"Chaillon","year":"2011","journal-title":"J Heart Lung Transplant"},{"key":"R33-4-20210218","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1053\/j.gastro.2010.08.002","article-title":"Ribavirin therapy inhibits viral replication on patients with chronic hepatitis E virus infection.","volume":"139","author":"Kamar","year":"2011","journal-title":"Gastroenterology"},{"issue":"Suppl 4","key":"R34-4-20210218","doi-asserted-by":"crossref","first-page":"S97","DOI":"10.1111\/j.1600-6143.2009.02899_1.x","article-title":"HHV-6, HHV-7 and HHV-8 in solid organ transplant recipients.","volume":"9","author":"Razonable","year":"2009","journal-title":"Am J Transplant"},{"key":"R35-4-20210218","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.3748\/wjg.15.2561","article-title":"Human herpesvirus 6 infections after liver transplantation.","volume":"15","author":"Abdel Massih","year":"2009","journal-title":"World J Gastroenterol"},{"key":"R36-4-20210218","doi-asserted-by":"crossref","first-page":"345","DOI":"10.4254\/wjh.v2.i9.345","article-title":"Impact of human herpes virus 6 in liver transplantation.","volume":"2","author":"Razonable","year":"2010","journal-title":"World J Hepatol"},{"key":"R37-4-20210218","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1093\/ndt\/gfr259","article-title":"Chromosomally integrated human herpesvirus-6 in kidney transplant recipients.","volume":"26","author":"Lee","year":"2011","journal-title":"Nephrol Dial Transplant"},{"key":"R38-4-20210218","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1097\/TP.0b013e318222444a","article-title":"Clinical significance of pretransplant chromosomally integrated human herpesvirus-6 in liver transplant recipients.","volume":"92","author":"Lee","year":"2011","journal-title":"Transplantation"},{"key":"R39-4-20210218","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1098\/rstb.2000.0777","article-title":"Molecular virology of Kaposis sarcoma-associated herpesvirus.","volume":"356","author":"Moore","year":"2001","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"R41-4-20210218","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1111\/j.1537-2995.2009.02559.x","article-title":"Human herpesvirus 8 genomes and seroprevalence in United States blood donors.","volume":"50","author":"Qu","year":"2010","journal-title":"Transfusion"},{"key":"R42-4-20210218","doi-asserted-by":"crossref","first-page":"2685","DOI":"10.1002\/ijc.22233","article-title":"Kaposis sarcoma risk among transplant recipients in the United States (1993-2003).","volume":"119","author":"Mbulaiteye","year":"2006","journal-title":"Int J Cancer"},{"key":"R43-4-20210218","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1093\/qjmed\/hci028","article-title":"Kaposis sarcoma in kidney transplant recipients: a 23-year experience.","volume":"98","author":"Moosa","year":"2005","journal-title":"Qjm"},{"key":"R44-4-20210218","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1111\/j.1432-2277.2008.00697.x","article-title":"Kaposis sarcoma and mTOR: a crossroad between viral infection neoangiogenesis and immunosuppression.","volume":"21","author":"Stallone","year":"2008","journal-title":"Transpl Int"},{"key":"R45-4-20210218","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1097\/TP.0b013e318193886e","article-title":"The role of mTOR inhibitors in the management of posttransplant malignancy.","volume":"87","author":"Monaco","year":"2009","journal-title":"Transplantation"},{"key":"R46-4-20210218","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1111\/j.1600-6143.2007.02110.x","article-title":"Human herpesvirus-8 (HHV-8)-associated primary effusion lymphoma in two renal transplant recipients receiving rapamycin.","volume":"8","author":"Boulanger","year":"2008","journal-title":"Am J Transplant"},{"key":"R47-4-20210218","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1086\/588820","article-title":"Valganciclovir for suppression of human herpesvirus-8 replication: a randomized, double-blind, placebo-controlled, crossover trial.","volume":"198","author":"Casper","year":"2008","journal-title":"J Infect Dis"},{"key":"R48-4-20210218","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1086\/504812","article-title":"Parvovirus B19 infection after transplantation: a review of 98 cases.","volume":"43","author":"Eid","year":"2006","journal-title":"Clin Infect Dis"},{"key":"R49-4-20210218","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jcv.2007.10.026","article-title":"Human bocavirus.","volume":"41","author":"Allander","year":"2008","journal-title":"J Clin Virol"},{"issue":"Suppl 4","key":"R50-4-20210218","doi-asserted-by":"crossref","first-page":"S284","DOI":"10.1093\/cid\/cir043","article-title":"Viral infections of the lower respiratory tract: old viruses, new viruses, and the role of diagnosis.","volume":"52","author":"Pavia","year":"2011","journal-title":"Clin Infect Dis"},{"key":"R51-4-20210218","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.3201\/eid1309.070318","article-title":"Disseminated bocavirus infection after stem cell transplant.","volume":"13","author":"Schenk","year":"2007","journal-title":"Emerg Infect Dis"},{"issue":"Suppl 4","key":"R52-4-20210218","doi-asserted-by":"crossref","first-page":"S147","DOI":"10.1111\/j.1600-6143.2009.02905.x","article-title":"Parvovirus B19 in solid organ transplant recipients.","volume":"9","author":"Eid","year":"2009","journal-title":"Am J Transplant"},{"key":"R53-4-20210218","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1034\/j.1399-3046.2001.00035.x","article-title":"Parvovirus B19 infection in pediatric solid-organ and bone marrow transplantation.","volume":"5","author":"Broliden","year":"2001","journal-title":"Pediatr Transplant"},{"key":"R54-4-20210218","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1007\/s100960000384","article-title":"Quantitative evidence for persistence of human parvovirus B19 DNA in an immunocompetent individual.","volume":"19","author":"Cassinotti","year":"2000","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"R55-4-20210218","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1007\/s00147-004-0779-3","article-title":"Progressive multifocal leukoencephalopathy in transplant recipients.","volume":"17","author":"Shitrit","year":"2005","journal-title":"Transpl Int"},{"key":"R56-4-20210218","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1128\/JCM.02008-10","article-title":"Reevaluating and optimizing polyomavirus BK and JC real-time PCR assays to detect rare sequence polymorphisms.","volume":"49","author":"Dumoulin","year":"2011","journal-title":"J Clin Microbiol"},{"key":"R57-4-20210218","doi-asserted-by":"crossref","first-page":"451","DOI":"10.3109\/13550289809114545","article-title":"The efficacy of nucleoside analogs against JC virus multiplication in a persistently infected human fetal brain cell line.","volume":"4","author":"Hou","year":"1998","journal-title":"J Neurovirol"},{"key":"R58-4-20210218","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.4065\/76.11.1171","article-title":"Cidofovir treatment of progressive multifocal leukoencephalopathy in a patient receiving highly active antiretroviral therapy.","volume":"76","author":"Razonable","year":"2001","journal-title":"Mayo Clin Proc"},{"key":"R59-4-20210218","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1002\/lt.20580","article-title":"Transmission of rabies virus from an organ donor to four transplant recipients.","volume":"11","author":"Kusne","year":"2005","journal-title":"Liver Transpl"},{"key":"R60-4-20210218","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/S0140-6736(88)92435-X","article-title":"Two rabies deaths after corneal grafts from one donor.","volume":"2","author":"Gode","year":"1988","journal-title":"Lancet"},{"key":"R61-4-20210218","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1056\/NEJM197903153001105","article-title":"Human-to-human transmission of rabies virus by corneal transplant.","volume":"300","author":"Houff","year":"1979","journal-title":"N Engl J Med"},{"key":"R62-4-20210218","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1056\/NEJMoa043018","article-title":"Transmission of rabies virus from an organ donor to four transplant recipients.","volume":"352","author":"Srinivasan","year":"2005","journal-title":"N Engl J Med"},{"key":"R63-4-20210218","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1001\/archneur.62.6.873","article-title":"Rabies encephalomyelitis: clinical, neuroradiological, and pathological findings in 4 transplant recipients.","volume":"62","author":"Burton","year":"2005","journal-title":"Arch Neurol"},{"key":"R64-4-20210218","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1086\/651267","article-title":"Management and outcomes after multiple corneal and solid organ transplantations from a donor infected with rabies virus.","volume":"50","author":"Maier","year":"2010","journal-title":"Clin Infect Dis"},{"key":"R65-4-20210218","doi-asserted-by":"crossref","first-page":"2196","DOI":"10.1056\/NEJMoa022987","article-title":"Transmission of West Nile virus from an organ donor to four transplant recipients.","volume":"348","author":"Iwamoto","year":"2003","journal-title":"N Engl J Med"},{"key":"R66-4-20210218","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1097\/01.TP.0000101435.91619.31","article-title":"Community-acquired West Nile virus infection in solid-organ transplant recipients.","volume":"77","author":"Kumar","year":"2004","journal-title":"Transplantation"},{"key":"R67-4-20210218","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1056\/NEJMoa030969","article-title":"Transmission of West Nile virus through blood transfusion in the United States in 2002.","volume":"349","author":"Pealer","year":"2003","journal-title":"N Engl J Med"},{"key":"R68-4-20210218","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1111\/j.1600-6143.2004.00519.x","article-title":"Screening for West Nile virus in organ transplantation: a medical decision analysis.","volume":"4","author":"Kiberd","year":"2004","journal-title":"Am J Transplant"},{"key":"R69-4-20210218","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1097\/01.qco.0000172697.44784.ff","article-title":"Emerging viral infections in transplant recipients.","volume":"18","author":"Kumar","year":"2005","journal-title":"Curr Opin Infect Dis"},{"key":"R70-4-20210218","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1111\/j.1600-6143.2004.00592.x","article-title":"Humar A: a seroprevalence study of West Nile virus infection in solid organ transplant recipients.","volume":"4","author":"Kumar","year":"2004","journal-title":"Am J Transplant"},{"key":"R71-4-20210218","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1001\/archneur.61.8.1210","article-title":"Naturally acquired West Nile virus encephalomyelitis in transplant recipients: clinical, laboratory, diagnostic, and neuropathological features.","volume":"61","author":"Kleinschmidt-DeMasters","year":"2004","journal-title":"Arch Neurol"},{"key":"R72-4-20210218","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1586\/14737159.3.6.733","article-title":"Serologic diagnosis of West Nile virus infection.","volume":"3","author":"Shi","year":"2003","journal-title":"Expert Rev Mol Diagn"},{"key":"R73-4-20210218","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1186\/1743-422X-8-360","article-title":"Simultaneous detection and differentiation of dengue virus serotypes 1-4, Japanese encephalitis virus, and West Nile virus by a combined reverse-transcription loop-mediated isothermal amplification assay.","volume":"8","author":"Li","year":"2011","journal-title":"Virol J"},{"key":"R74-4-20210218","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1086\/315847","article-title":"Ribavirin inhibits West Nile virus replication and cytopathic effect in neural cells.","volume":"182","author":"Jordan","year":"2000","journal-title":"J Infect Dis"},{"key":"R75-4-20210218","doi-asserted-by":"crossref","first-page":"107","DOI":"10.3201\/eid0801.010252","article-title":"Efficacy of interferon alpha-2b and ribavirin against West Nile virus in vitro.","volume":"8","author":"Anderson","year":"2002","journal-title":"Emerg Infect Dis"},{"key":"R76-4-20210218","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1128\/JVI.02155-10","article-title":"Human IgG subclasses: in vitro neutralization of and in vivo protection against West Nile virus.","volume":"85","author":"Hofmeister","year":"2011","journal-title":"J Virol"}],"container-title":["Current Opinion in Organ Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MOT.0b013e32834cdaf2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T03:55:19Z","timestamp":1620964519000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00075200-201112000-00004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12]]},"references-count":75,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.1097\/mot.0b013e32834cdaf2","relation":{},"ISSN":["1087-2418"],"issn-type":[{"value":"1087-2418","type":"print"}],"subject":[],"published":{"date-parts":[[2011,12]]}}}